Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sinapic acid is a naturally occurring hydroxycinnamic acid and a member of the phenylpropanoid family. It is widely distributed in the plant kingdom and found in various fruits, vegetables, cereal grains, oilseed crops, spices, and medicinal plants. Sinapic acid is best known as a matrix for matrix-assisted laser desorption/ionization (MALDI) mass spectrometry due to its ability to absorb laser radiation and donate protons to analytes. Biologically, it exhibits antioxidant, anti-inflammatory, antimicrobial (including antibacterial), antidiabetic, anticancer and anti-anxiety activities demonstrated primarily in preclinical studies. Mechanistically it acts as an inhibitor of histone deacetylase (HDAC) with an IC50 of 2.27 mM and also inhibits angiotensin-converting enzyme I (ACE-I). It has been shown to reduce cholesterol and triglyceride levels as well as improve oxidative stress parameters in animal models[1][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sinapic acid.